Literature DB >> 19020109

Cross-reactivity of Paracoccidioides brasiliensis, Histoplasma capsulatum, and Cryptococcus species in the commercial Platelia Aspergillus enzyme immunoassay.

Melissa O Xavier1, Alessandro C Pasqualotto, Isabel Cristina E Cardoso, Luiz Carlos Severo.   

Abstract

Cross-reactivity in the Platelia Aspergillus enzyme immunoassay was evaluated using 120 sera from patients with paracoccidioidomycosis, histoplasmosis, and cryptococcosis. At a cutoff value of 0.5, positivity rates were 50%, 67%, and 50%, respectively. The implications for these findings are discussed.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19020109      PMCID： PMC2620656          DOI： 10.1128/CVI.00310-08

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  9 in total

1.  False-positive Aspergillus galactomannan (GM) assay in histoplasmosis.

Authors:  Suneetha Narreddy; Pranatharthi H Chandrasekar
Journal:  J Infect       Date:  2007-11-05       Impact factor: 6.072

2.  Galactoxylomannan does not exhibit cross-reactivity in the platelia Aspergillus enzyme immunoassay.

Authors:  Magdia De Jesus; Emily Hackett; Michelle Durkin; Patricia Connolly; Arturo Casadevall; Ruta Petraitiene; Thomas J Walsh; L Joseph Wheat
Journal:  Clin Vaccine Immunol       Date:  2007-03-14

3.  Cryptococcus neoformans Galactoxylomannan contains an epitope(s) that is cross-reactive with Aspergillus Galactomannan.

Authors:  Frédéric Dalle; Pierre Emmanuel Charles; Karine Blanc; Denis Caillot; Pascal Chavanet; Françoise Dromer; Alain Bonnin
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

4.  Aspergillus galactomannan enzyme-linked immunosorbent assay cross-reactivity caused by invasive Geotrichum capitatum.

Authors:  Mareva Giacchino; Nadia Chiapello; Stefania Bezzio; Franca Fagioli; Paola Saracco; Alda Alfarano; Vincenza Martini; Giuseppe Cimino; Pietro Martino; Corrado Girmenia
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

5.  Detection of circulating galactomannan in serum samples for diagnosis of Penicillium marneffei infection and cryptococcosis among patients infected with human immunodeficiency virus.

Authors:  Yu-Tsung Huang; Chien-Ching Hung; Chun-Hsing Liao; Hsin-Yun Sun; Shan-Chwen Chang; Yee-Chun Chen
Journal:  J Clin Microbiol       Date:  2007-06-27       Impact factor: 5.948

6.  Reactivity of platelia Aspergillus galactomannan antigen with piperacillin-tazobactam: clinical implications based on achievable concentrations in serum.

Authors:  Nina Singh; Asia Obman; Shahid Husain; Sherrie Aspinall; Sue Mietzner; Janet E Stout
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

Review 7.  Paracoccidioides brasiliensis: chemical and molecular tools for research on cell walls, antifungals, diagnosis, taxonomy.

Authors:  Gioconda San-Blas; Gustavo Niño-Vega
Journal:  Mycopathologia       Date:  2008 Apr-May       Impact factor: 2.574

8.  Histoplasmosis-associated cross-reactivity in the BioRad Platelia Aspergillus enzyme immunoassay.

Authors:  L Joseph Wheat; Emily Hackett; Michelle Durkin; Patricia Connolly; Ruta Petraitiene; Thomas J Walsh; Kenneth Knox; Chadi Hage
Journal:  Clin Vaccine Immunol       Date:  2007-03-07

Review 9.  Update on the contribution of galactomannan for the diagnosis of invasive aspergillosis.

Authors:  Valério R Aquino; Luciano Z Goldani; Alesssandro C Pasqualotto
Journal:  Mycopathologia       Date:  2007-04-05       Impact factor: 3.785
  9 in total
  15 in total

1.  Cross-reactivity of Fusarium spp. in the Aspergillus Galactomannan enzyme-linked immunosorbent assay.

Authors:  Anna Maria Tortorano; Maria Carmela Esposto; Anna Prigitano; Anna Grancini; Cristina Ossi; Caterina Cavanna; Giuliana Lo Cascio
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

2.  Western blotting is an efficient tool for differential diagnosis of paracoccidioidomycosis and pulmonary tuberculosis.

Authors:  Thâmara Aline Bertoni; Maysa Cláudia Zolin Perenha-Viana; Eliana Valéria Patussi; Rosilene Fressatti Cardoso; Terezinha Inez Estivalet Svidzinski
Journal:  Clin Vaccine Immunol       Date:  2012-09-12

Review 3.  Fungal diagnostics.

Authors:  Thomas R Kozel; Brian Wickes
Journal:  Cold Spring Harb Perspect Med       Date:  2014-04-01       Impact factor: 6.915

4.  Cross-reactivity of Aspergillus galactomannan in an HIV-infected patient with histoplasmosis.

Authors:  Zaw Min; John W Baddley; Jorge M Rodriguez; Stephen A Moser; Mukesh Patel
Journal:  Med Mycol Case Rep       Date:  2012-11-05

5.  Identification of histoplasma-specific peptides in human urine.

Authors:  David K Crockett; Mark M Kushnir; Joann L Cloud; Edward R Ashwood; Alan L Rockwood
Journal:  Int J Pept       Date:  2012-03-26

6.  Evaluation of the Double Agar Gel Immunodiffusion Test and of the Enzyme-Linked Immunosorbent Assay in the Diagnosis and Follow-Up of Patients with Chronic Pulmonary Aspergillosis.

Authors:  Priscila Zacarias de Azevedo; Tatiane Fernanda Sylvestre; Ricardo de Souza Cavalcante; Lídia Raquel de Carvalho; Daniela Vanessa Moris; Maria Luiza Cotrim Sartor de Oliveira; Rinaldo Poncio Mendes
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

Review 7.  New Insights into HIV/AIDS-Associated Cryptococcosis.

Authors:  Spinello Antinori
Journal:  ISRN AIDS       Date:  2013-02-25

Review 8.  Histoplasmosis in HIV-Infected Patients: A Review of New Developments and Remaining Gaps.

Authors:  Antoine A Adenis; Christine Aznar; Pierre Couppié
Journal:  Curr Trop Med Rep       Date:  2014-03-28

9.  Immunoproteome of Aspergillus fumigatus using sera of patients with invasive aspergillosis.

Authors:  Emylli D Virginio; Paula H Kubitschek-Barreira; Marjorie Vieira Batista; Marcelo R Schirmer; Eliana Abdelhay; Maria A Shikanai-Yasuda; Leila M Lopes-Bezerra
Journal:  Int J Mol Sci       Date:  2014-08-20       Impact factor: 5.923

10.  Novel mouse monoclonal antibodies specifically recognize Aspergillus fumigatus galactomannan.

Authors:  Andrey L Matveev; Vadim B Krylov; Ljudmila A Emelyanova; Arsenii S Solovev; Yana A Khlusevich; Ivan K Baykov; Thierry Fontaine; Jean-Paul Latgé; Nina V Tikunova; Nikolay E Nifantiev
Journal:  PLoS One       Date:  2018-03-08       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.